Tafalgie Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Marseille
Business model:B2B
Tafalgie Therapeutics is a biotech startup in France developing non-opioid treatments for pain - next-generation analgesics that modulate pain signals through TAFA4 protein-derived compounds. Its aim is to address acute, chronic, neuropathic, inflammatory, and post-operative pain without the risks associated with conventional painkillers such as respiratory issues, sedation, tolerance, and addiction.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 13.98M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Tafalgie Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Ability Pharma
63%
|
|
![]() |
AbolerIS Pharma
63%
|
|
![]() |
Acesion Pharma
63%
|
|
![]() |
Beckley Psytech
63%
|
|
![]() |
CatalYm
63%
|
|
![]() |
Cinclus Pharma
63%
|
|
![]() |
Citryll
63%
|
|
![]() |
Inbrain Neuroelectronics
63%
|
|
![]() |
InnovaFeed SAS
63%
|
|
![]() |
Memo Therapeutics
63%
|
|